Published on
February 17, 2026
- 14:00 GMT
Mandara Biopharma Receives FDA Approval to Launch Their Clinical Trials for Alzheimer’s Agitation
Mandara Biopharma Inc. announced approval from the FDA to initiate their clinical trials for the treatment of agitation associated with Alzheimer’s disease. BOULDER, CO, UNITED STATES, February 17, 2026 /EINPresswire.com/ -- Mandara Biopharma Inc., a …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
